遺伝性非ポリポーシス大腸癌 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "遺伝性非ポリポーシス大腸癌" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

low place

979^th place

low place

low place

3,257^th place

6,629^th place

1allenpress.com

4,512^th place

low place

1oxfordjournals.org

1,389^th place

1,710^th place

low place

low place

1annalsnyas.org

low place

low place

222^nd place

498^th place

1,226^th place

1,988^th place

low place

low place

2,374^th place

2,486^th place

719^th place

3,311^th place

low place

low place

5^th place

19^th place

low place

low place

low place

low place

allenpress.com

journals.allenpress.com

Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (November 2005). “Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability”. Arch. Pathol. Lab. Med. 129 (11): 1390–7. PMID 16253017.

ama-assn.org

archinte.ama-assn.org

Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (February 1966). “Hereditary factors in cancer. Study of two large midwestern kindreds”. Arch. Intern. Med. 117 (2): 206–12. doi:10.1001/archinte.117.2.206. PMID 5901552.

annalsnyas.org

Pathology of Hereditary Nonpolyposis Colorectal Cancer - JASS 910 (1): 62 - Annals of the New York Academy of Sciences

bmj.com

gut.bmj.com

Ramsoekh D, Wagner A, van Leerdam ME, et al. (November 2008). “A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting”. Gut 57 (11): 1539–44. doi:10.1136/gut.2008.156695. PMID 18625694.

creighton.edu

medicine.creighton.edu

School of Medicine :: Hereditary Cancer Center :: Creighton University

doi.org

Kastrinos F, Mukherjee B, Tayob N, et al. (October 2009). “Risk of pancreatic cancer in families with Lynch syndrome”. JAMA 302 (16): 1790–5. doi:10.1001/jama.2009.1529. PMID 19861671.
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (February 1966). “Hereditary factors in cancer. Study of two large midwestern kindreds”. Arch. Intern. Med. 117 (2): 206–12. doi:10.1001/archinte.117.2.206. PMID 5901552.
Bellizzi AM, Frankel WL (2009). “Colorectal cancer due to deficiency in DNA mismatch repair function: a review”. Advances in Anatomic Pathology 16 (6): 405–417. doi:10.1097/PAP.0b013e3181bb6bdc. PMID 19851131.
Lipton LR, Johnson V, Cummings C, et al. (December 2004). “Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic”. J. Clin. Oncol. 22 (24): 4934–43. doi:10.1200/JCO.2004.11.084. PMID 15611508.
Fishel R, Lescoe M, Rao M, Copeland N, Jenkins N, Garber J, Kane M, Kolodner R (1993). “The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer”. Cell 75 (5): 1027–38. doi:10.1016/0092-8674(93)90546-3. PMID 8252616.
Papadopoulos N, Nicolaides N, Wei Y, Ruben S, Carter K, Rosen C, Haseltine W, Fleischmann R, Fraser C, Adams M (1994). “Mutation of a mutL homolog in hereditary colon cancer”. Science 263 (5153): 1625–9. doi:10.1126/science.8128251. PMID 8128251.
Thompson E, Meldrum CJ, Crooks R, et al. (March 2004). “Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations”. Clin. Genet. 65 (3): 215–25. doi:10.1111/j.1399-0004.2004.00214.x. PMID 14756672.
Nicolaides NC, Papadopoulos N, Liu B, et al. (September 1994). “Mutations of two PMS homologues in hereditary nonpolyposis colon cancer”. Nature 371 (6492): 75–80. doi:10.1038/371075a0. PMID 8072530.
Lu SL, Kawabata M, Imamura T, et al. (May 1998). “HNPCC associated with germline mutation in the TGF-beta type II receptor gene”. Nat. Genet. 19 (1): 17–8. doi:10.1038/ng0598-17. PMID 9590282.
Ou J, Rasmussen M, Westers H, et al. (April 2009). “Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome”. Genes Chromosomes Cancer 48 (4): 340–50. doi:10.1002/gcc.20644. PMID 19156873.
Ramsoekh D, Wagner A, van Leerdam ME, et al. (November 2008). “A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting”. Gut 57 (11): 1539–44. doi:10.1136/gut.2008.156695. PMID 18625694.
Suchy J, Lubinski J (2008). “MSH6 syndrome”. Hered Cancer Clin Pract 6 (2): 103–104. doi:10.1186/1897-4287-6-2-103. PMC 2735474. PMID 19804606.
Goldberg Y, Porat RM, Kedar I, et al. (October 2009). “An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC”. Fam. Cancer 9 (2): 141–50. doi:10.1007/s10689-009-9298-9. PMID 19851887.
Burn J, Bishop DT, Mecklin JP, et al. (December 2008). “Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome”. N. Engl. J. Med. 359 (24): 2567–78. doi:10.1056/NEJMoa0801297. PMID 19073976.

jco.org

Lipton LR, Johnson V, Cummings C, et al. (December 2004). “Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic”. J. Clin. Oncol. 22 (24): 4934–43. doi:10.1200/JCO.2004.11.084. PMID 15611508.

medscape.com

“Aspirin Confers Long-Term Protective Effect in Lynch Syndrome Patients”. 2009年11月7日閲覧。

mymed.jp

冨田尚裕 (2008年6月11日). “遺伝性非ポリポーシス大腸癌”. MyMed医療電子教科書. 2010年8月21日閲覧。

nejm.org

content.nejm.org

Burn J, Bishop DT, Mecklin JP, et al. (December 2008). “Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome”. N. Engl. J. Med. 359 (24): 2567–78. doi:10.1056/NEJMoa0801297. PMID 19073976.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kastrinos F, Mukherjee B, Tayob N, et al. (October 2009). “Risk of pancreatic cancer in families with Lynch syndrome”. JAMA 302 (16): 1790–5. doi:10.1001/jama.2009.1529. PMID 19861671.
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (February 1966). “Hereditary factors in cancer. Study of two large midwestern kindreds”. Arch. Intern. Med. 117 (2): 206–12. doi:10.1001/archinte.117.2.206. PMID 5901552.
Bellizzi AM, Frankel WL (2009). “Colorectal cancer due to deficiency in DNA mismatch repair function: a review”. Advances in Anatomic Pathology 16 (6): 405–417. doi:10.1097/PAP.0b013e3181bb6bdc. PMID 19851131.
Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (November 2005). “Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability”. Arch. Pathol. Lab. Med. 129 (11): 1390–7. PMID 16253017.
Umar A, Boland CR, Terdiman JP, et al. (February 2004). “Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability”. J. Natl. Cancer Inst. 96 (4): 261–8. PMID 14970275.
Lipton LR, Johnson V, Cummings C, et al. (December 2004). “Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic”. J. Clin. Oncol. 22 (24): 4934–43. doi:10.1200/JCO.2004.11.084. PMID 15611508.
Fishel R, Lescoe M, Rao M, Copeland N, Jenkins N, Garber J, Kane M, Kolodner R (1993). “The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer”. Cell 75 (5): 1027–38. doi:10.1016/0092-8674(93)90546-3. PMID 8252616.
Papadopoulos N, Nicolaides N, Wei Y, Ruben S, Carter K, Rosen C, Haseltine W, Fleischmann R, Fraser C, Adams M (1994). “Mutation of a mutL homolog in hereditary colon cancer”. Science 263 (5153): 1625–9. doi:10.1126/science.8128251. PMID 8128251.
Thompson E, Meldrum CJ, Crooks R, et al. (March 2004). “Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations”. Clin. Genet. 65 (3): 215–25. doi:10.1111/j.1399-0004.2004.00214.x. PMID 14756672.
Nicolaides NC, Papadopoulos N, Liu B, et al. (September 1994). “Mutations of two PMS homologues in hereditary nonpolyposis colon cancer”. Nature 371 (6492): 75–80. doi:10.1038/371075a0. PMID 8072530.
Lu SL, Kawabata M, Imamura T, et al. (May 1998). “HNPCC associated with germline mutation in the TGF-beta type II receptor gene”. Nat. Genet. 19 (1): 17–8. doi:10.1038/ng0598-17. PMID 9590282.
Ou J, Rasmussen M, Westers H, et al. (April 2009). “Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome”. Genes Chromosomes Cancer 48 (4): 340–50. doi:10.1002/gcc.20644. PMID 19156873.
Ramsoekh D, Wagner A, van Leerdam ME, et al. (November 2008). “A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting”. Gut 57 (11): 1539–44. doi:10.1136/gut.2008.156695. PMID 18625694.
Suchy J, Lubinski J (2008). “MSH6 syndrome”. Hered Cancer Clin Pract 6 (2): 103–104. doi:10.1186/1897-4287-6-2-103. PMC 2735474. PMID 19804606.
Goldberg Y, Porat RM, Kedar I, et al. (October 2009). “An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC”. Fam. Cancer 9 (2): 141–50. doi:10.1007/s10689-009-9298-9. PMID 19851887.
Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453-6. PMID 10348829.
Burn J, Bishop DT, Mecklin JP, et al. (December 2008). “Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome”. N. Engl. J. Med. 359 (24): 2567–78. doi:10.1056/NEJMoa0801297. PMID 19073976.

ncbi.nlm.nih.gov

http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim
Suchy J, Lubinski J (2008). “MSH6 syndrome”. Hered Cancer Clin Pract 6 (2): 103–104. doi:10.1186/1897-4287-6-2-103. PMC 2735474. PMID 19804606.

pmc.ncbi.nlm.nih.gov

Suchy J, Lubinski J (2008). “MSH6 syndrome”. Hered Cancer Clin Pract 6 (2): 103–104. doi:10.1186/1897-4287-6-2-103. PMC 2735474. PMID 19804606.

oncolink.org

The Abramson Cancer Center of the University of Pennsylvania (January 6, 2002). “OncoLink eNews: On the Forefront of Colorectal Cancer, Winter 2002”. OncoLink. 2010年8月21日閲覧。

ono.co.jp

http://www.ono.co.jp/jpnw/PDF/n17_0803.pdf

oxfordjournals.org

jnci.oxfordjournals.org

Umar A, Boland CR, Terdiman JP, et al. (February 2004). “Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability”. J. Natl. Cancer Inst. 96 (4): 261–8. PMID 14970275.

shouman.jp

http://www.shouman.jp/details/10_2_16.html

umin.jp

jsft.umin.jp

http://jsft.umin.jp/hp/msikensa.html

grj.umin.jp

http://grj.umin.jp/grj/hnpcc.htm

wiley.com

www3.interscience.wiley.com

Thompson E, Meldrum CJ, Crooks R, et al. (March 2004). “Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations”. Clin. Genet. 65 (3): 215–25. doi:10.1111/j.1399-0004.2004.00214.x. PMID 14756672.

worldcat.org

search.worldcat.org

野水整、権田憲士他「わが国における遺伝性非ポリポーシス大腸癌の臨床的検討　－文献的考察－」『家族性腫瘍』第4巻第1号、2004年、p.p.42-48、ISSN 1346-1052。